Coronary Artery Risk Development in Young Adults (CARDIA)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005130
First received: May 25, 2000
Last updated: April 12, 2016
Last verified: April 2009
  Purpose
To measure changes in coronary heart disease risk factors in cohorts of Black and white males and females 18 to 30 years of age at baseline. Also, to identify life styles during this age span which influence these changes in risk factors.

Condition
Cardiovascular Diseases
Coronary Disease
Hypertension
Heart Diseases
Obesity
Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: January 1984
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Black and white males and females 18 to 30 years of age at baseline.
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005130

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Jeffrey Carr Wake Forest School of Medicine
Principal Investigator: Robert Detrano Harbor-UCLA Research and Development Institute
Principal Investigator: Cora Lewis University of Alabama at Birmingham
Principal Investigator: Kiang Liu Northwestern University
Principal Investigator: Daniel O'Leary Tufts Medical Center
Principal Investigator: Pamela Schreiner University of Minnesota - Clinical and Translational Science Institute
Principal Investigator: Stephen Sidney Kaiser Foundation Research Institute
Principal Investigator: O. Williams University of Alabama at Birmingham
Principal Investigator: Nathan Wong University of California at Irvine
  More Information

Additional Information:
Publications:
For a bibliography see http://www.cardia.dopm.uab.edu/

Study Data/Documents: Individual Participant Data Set  This link exits the ClinicalTrials.gov site
Identifier: CARDIA
NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00005130     History of Changes
Other Study ID Numbers: 1000 
Study First Received: May 25, 2000
Last Updated: April 12, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Coronary Artery Disease
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on July 28, 2016